type here...

CATEGORIES

Press Release

LATEST

1...9101112Page 10 of 12

TRENDING

EDITORS CHOICE

Private Practice: Solution Mode to Survival Mode

Medika Life -
A true glimpse into the process of transitioning a practice and how it can be a great solution to the issues facing private practices. Many are struggling,

Voluntary Recall: Two Lots of NP Thyroid® Tablets, Due to Sub Potency

Medika Life -
Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.

First “Global State of Digital Health Report” Tapping into 200 Million Data Points Examines More Than 12,000 Digital Health Ventures Now Available

Medika Life -
Breaking Digital Health Report Will Guide C-Suite Entrepreneurs and Private Equity Investment Strategies

AURA™ adds Protein/Non Protein Identification to Horizon®

Medika Life -
Aura revolutionizes biologic stability analysis, enabling simple protein and non-protein aggregate identification in formulation development and analytical testing

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories